|Home||» Products||» Antidiabetic Hypoglycemic Drugs||» Voglibose|
- Minimum Order Quantity
PRANDIAL MD is indicated as an adjunct to diet and exercise to improve postprandial hyperglycaemiain patients with type 2 diabetes. PRANDIAL MD may also be used in combination with a sulphonylurea when diet plus either PRANDIAL MD or a sulphonylurea alone do not result in adequate glycaemic control. The effect of PRANDIAL MD to enhance glycaemic control is additive to that of sulphonylureas when used in combination, presumably because its mechanism of action is different.
- Main Export Market(s)
- Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia